Harm Reduction Legal Project, Network for Public Health Law, Los Angeles, CA.
ChangeLab Solutions, Oakland, CA.
Ann Emerg Med. 2021 Jul;78(1):102-108. doi: 10.1016/j.annemergmed.2021.01.017. Epub 2021 Mar 27.
Treatment with buprenorphine significantly reduces both all-cause and overdose mortality among individuals with opioid use disorder. Offering buprenorphine treatment to individuals who experience a nonfatal opioid overdose represents an opportunity to reduce opioid overdose fatalities. Although some emergency departments (EDs) initiate buprenorphine treatment, many individuals who experience an overdose either refuse transport to the ED or are transported to an ED that does not offer buprenorphine. Emergency medical services (EMS) professionals can help address this treatment gap. In this Concepts article, we describe the federal legal landscape that governs the ability of EMS professionals to administer buprenorphine treatment, and discuss state and local regulatory considerations relevant to this promising and emerging practice.
丁丙诺啡治疗可显著降低阿片类药物使用障碍患者的全因死亡率和过量死亡率。为经历非致命性阿片类药物过量的个体提供丁丙诺啡治疗，是减少阿片类药物过量死亡的一个机会。尽管一些急诊科 (ED) 开始使用丁丙诺啡治疗，但许多经历过量的个体要么拒绝被送往 ED，要么被送往不提供丁丙诺啡的 ED。紧急医疗服务 (EMS) 专业人员可以帮助解决这一治疗缺口。在这篇概念文章中，我们描述了管理 EMS 专业人员管理丁丙诺啡治疗能力的联邦法律环境，并讨论了与这一有前途和新兴实践相关的州和地方监管考虑因素。
